Third Party Storage. After the time frame set forth in Section 3.5.1, Baxter shall be permitted to store Product in third party storage facilities qualified by Baxter; such qualified facilities shall be at the discretion of Baxter; provided however that, prior to storing any Product at a third party storage facility, Baxter shall notify Celator in writing of ▇▇▇▇▇▇’▇ intent to do so and shall provide the name of the third party and the location of the storage facility.
Appears in 3 contracts
Sources: Clinical and Commercial Manufacturing and Supply Agreement (Jazz Pharmaceuticals PLC), Clinical and Commercial Manufacturing and Supply Agreement (Celator Pharmaceuticals Inc), Clinical and Commercial Manufacturing and Supply Agreement (Celator Pharmaceuticals Inc)